Latest Key Hires & Board Changes In Cannabis Industry: Canopy Growth, Acreage And More
Leadership Changes in Cannabis Industry:
- Margaret Brodie nominated as EY Entrepreneur Of The Year 2024 finalist for Rubicon Organics Inc.
- Canopy Growth Corporation appoints Ryan Keith as head of clinics.
- Acreage Holdings names Rebecca Kirk as chief operating officer effective July 1, 2024.
- Charlotte’s Web Holdings appoints Erika Lind as CFO, replacing Jessica Saxton.
- MyMD Pharmaceuticals appoints Mitchell Glass, M.D., as president and chief medical officer.
Board of Directors Elections and Resignations:
- TerrAscend Corp. elects new directors including Craig Collard and Kara DioGuardi.
- Nova Cannabis Inc. elects Zachary George and Marcie Kiziak to the board.
- Wendy Berger steps down from Green Thumb Industries' board after nearly a decade of service.
Insights from Wendy Berger:
- Berger focuses on future participation in the cannabis industry and her business, WBS Equities, LLC.
- She emphasizes looking ahead and not dwelling on the past, sharing valuable insights at Benzinga events.
Trade with 70% Backtested Accuracy
Analyst Views on CWEB

No data
About the author

- Rate Policy Stability: The People's Bank of China maintained the one-year and five-year loan prime rates at 3.0% and 3.5%, respectively, extending an eight-month streak of policy stability, which underscores its commitment to market expectations and aims to ensure smooth economic operations.
- Economic Growth Data: China's economy expanded by 4.5% year-on-year in Q4 2025, marking the slowest growth in three years; however, the full-year growth reached 5%, meeting government targets, reflecting both challenges and achievements in economic recovery.
- Market Reaction: On Tuesday, the Shanghai Composite fell 0.3% to around 4,100, while the Shenzhen Component dropped 1.7% to 14,050, indicating cautious investor sentiment influenced by the unchanged interest rates and economic outlook.
- Currency Stability: The offshore yuan steadied at around 6.96 per dollar, close to 32-month highs, suggesting strong market confidence in the yuan amid the PBoC's decision to keep lending rates unchanged, potentially aiding in attracting foreign investment.
Trade Tensions Impacting Exports: Tariffs and trade tensions between the U.S. and China have significantly affected China's export dynamics, leading to a $75 billion decline in exports to the U.S. while exports to Asia surged by $150 billion in 2025.
Regional Market Shift: Chinese exporters are adapting to geopolitical pressures by redirecting goods to faster-growing regional markets, particularly in Asia, rather than pursuing broad global expansion.
Manufacturing Activity Resilience: Despite the decline in U.S.-bound shipments, Chinese manufacturing activity has not contracted, indicating a strategic pivot towards regional trade.
Stable Exports to Other Regions: Shipments to Europe, Africa, and Latin America have remained largely unchanged, suggesting a concentrated focus on trade within Asia rather than a global diversification strategy.
Appointment of New CFO: Aclarion, Inc. has appointed Greg Gould as Chief Financial Officer, succeeding John Lorbiecki, who is retiring. Gould brings over 30 years of experience in public and private companies, focusing on growth and shareholder value.
Company's Focus and Technology: Aclarion is a healthcare technology firm that utilizes biomarkers and AI algorithms to assist physicians in identifying chronic low back pain. Their Nociscan platform is the first evidence-supported SaaS solution designed to differentiate between painful and nonpainful lumbar discs.
Stimulus Measures Announced: China's central bank has implemented a series of stimulus measures, including cutting the reverse repurchase rate and reserve requirement ratio to support economic growth amid trade tensions, with additional measures targeting small and medium enterprises expected.
Trade Dialogue and Market Reactions: A meeting between China’s Vice Premier and U.S. Treasury Secretary is set to occur, marking a potential easing of trade tensions, while investors are advised to approach leveraged China ETFs cautiously due to their volatility and short-term nature.

Market Reactions to Trade Policies: Asia-Pacific markets showed mixed results as investors awaited clarity on President Trump's trade policies, with potential flexibility in tariffs and ongoing tensions in the Middle East affecting market sentiment.
Economic Indicators from Japan and Australia: Japan's private sector activity contracted for the first time in five months, while Australia's manufacturing sector saw its fastest expansion in over two years, alongside upcoming federal budget announcements aimed at economic resilience.
Market Performance: Asia-Pacific markets showed mixed results, with Japan's Topix Index rising while the Nikkei fell, and significant declines in China and Hong Kong. India's SENSEX and Australia's AS51 saw gains amid cautious trading influenced by U.S. economic data and global trade concerns.
Economic Indicators: Japan's core inflation rate slowed to 3% in February, exceeding forecasts, while China's lending rates remained unchanged. OPEC+ announced output cuts, and U.S. stock futures indicated a potential end to a four-week losing streak for major indexes.








